EXTEND (Eltrombopag Extended Dosing Study)

Clinical trial NCT00351468 · COMPLETED

Trial details

NCT number: NCT00351468
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2006-06-01
Primary completion: 2015-07-01
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.